|
WO2018019188A1
|
|
Polymorph of nucleoside phosphoramidate prodrug and preparation method therefor
|
|
CN107118247A
|
|
The preparation method of selamectin
|
|
CN106749251A
|
|
A kind of synthesis of entecavir midbodies and method of purification
|
|
CN106866650A
|
|
A kind of synthesis of MFG and method of purification
|
|
CN106800593A
|
|
A kind of method for purifying anidulafungin precursor compound
|
|
CN106854228A
|
|
A kind of preparation method of Elidel
|
|
CN106905519A
|
|
Biodegradable amphiphilic polymers, polymer vesicle prepared therefrom and the application in targeted therapy of lung cancer medicine is prepared
|
|
CN106749201A
|
|
A kind of preparation method of Walla handkerchief sand and its intermediate
|
|
CN106727363A
|
|
The pharmaceutical composition of the lyophilized form of nucleoside phosphoramidate class prodrug
|
|
CN106674318A
|
|
NS5B polymerase inhibitor
|
|
CN106674320A
|
|
HCV (Hepatitis C Virus) therapeutic drug
|
|
CN106674319A
|
|
Compound for treating hepatitis C
|
|
CN106674333A
|
|
Cyclic peptide antifungal compound and preparation method thereof
|
|
CN106045934A
|
|
Crystal form of intermediate used for synthesis of tedizolid
|
|
CN106554403A
|
|
Exenatide trim and application thereof
|
|
CN106554404A
|
|
A kind of Exenatide trim and application thereof
|
|
CN106478608A
|
|
The crystalline polymorph of the husky sulfate of Walla handkerchief
|
|
CN105693824A
|
|
Method for reducing micafungin sodium raw material drug solvent residual amount
|
|
CN106478663A
|
|
A kind of drying meanss of everolimuses
|
|
CN106279282A
|
|
A kind of purification process of Tedizolid Phosphate
|
